MedTrace Logo

Hyaluronic Acid and Vaginal Distress

NCT00890487 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2009-04-29

No results posted yet for this study

Summary

The purpose of this trial is to study the effects of the oral supplementation hyaluronic acid in menopause women with vaginal distress for treatment vaginal distress.

Conditions

  • Vaginal Disease

Interventions

OTHER

hyaluronic acid pill

pill, 220 mg, once a day, three months

Sponsors & Collaborators

  • University of Messina

    lead OTHER

Principal Investigators

  • Tindara TL La Galia, PhD student · Centre Menopause

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890487 on ClinicalTrials.gov